์ฝ”๋กœ๋‚˜19(COVID-19) ๋Œ€์‘ - ํŒฌ๋ฐ๋ฏน ๊ธฐ๊ฐ„ ์ค‘ ๋ฐฑ์‹  ๋ฐ ์น˜๋ฃŒ์ œ ๊ด€๋ จ ์—ฐ๊ตฌ๋ฅผ ์œ„ํ•œ ์ง€์›์„ ์•„๋ผ์ง€ ์•Š๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค. ์ž์„ธํžˆ ์•Œ์•„๋ณด๊ธฐย 

WEBINAR

3D Cell Imaging

Optimizing high-content screening tools for physiologically-relevant 3D in vitro models

Overcome challenges in high-throughput 3D imaging

Optimizing high-content screening tools for physiologically-relevant 3D in vitro models

Elodie Vandenhaute, Study Director | HCS Pharma
Zied Souguir, Senior Scientist | HCS Pharma
Dan Oโ€™Connor, North America Bioimaging Director | Molecular Devices

Watch our webinar with HCS Pharma, a biotechnology start-up company based in France, as we discuss the biological characterization of cells in 3D matrices for liver, brain and adipose tissues, and cancer modeling, using BIOMIMESYSยฎ hydroscaffold technology. We also discuss high-content screening solutions for examining 3D in vitro models.

Key learning objectives:

  • Describe the differentiating factors between different 3D cell culture systems
  • Utilizing a relevant 3D cell culture platform for liver, brain, adipose tissue, and disease modeling (human cells)
  • Optimizing setup of a high-content screening platform for 3D in vitro models

Register to view webinar on demand